Eagle Health Investments LP
Filing Date
Global Rank
#2,380
/ 8,232
▲ 237
Top Industry
Biotechnology
61.9%
3Y Alpha vs SPY
-9.3%
Period ended 2 months ago
Filed May 15, 2026 · 30d
22 quarters · since Dec 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+38.6%
SPY
+76.3%
Annualised alpha
-9.3%
Max drawdown
−29.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
26 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.6%
−0.1 pts
Top 5
39.6%
−6.6 pts
Top 10
63.2%
−8.5 pts
HHI
558
Diversified−77
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.9% | $478,133,227 |
| Financial Services | 0.1% | $413,415 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | +541,039 | 2,060,427 | $11,394,161 | |
| PRCT | PROCEPT BioRobotics Corp | +265,381 | 573,815 | $14,351,113 | |
| ALKS | Alkermes plc. | +156,873 | 238,673 | $8,439,477 | |
| BMRN | Biomarin Pharmaceutical Inc | +138,997 | 505,809 | $28,573,150 | |
| TERN | Terns Pharmaceuticals, Inc. | +137,407 | 412,497 | $21,746,841 | |
| SRRK | Scholar Rock Holding Corp | +130,719 | 494,019 | $24,285,974 | |
| PTGX | Protagonist Therapeutics, Inc | +122,022 | 179,322 | $18,900,538 | |
| ICLR | Icon PLC | +111,410 | 358,500 | $39,671,610 | |
| CNTA | Centessa Pharmaceuticals plc | +111,191 | 214,291 | $8,511,638 | |
| FTRE | Fortrea Holdings Inc. | +89,000 | 1,307,560 | $12,317,215 | |
| GH | Guardant Health, Inc. | +26,181 | 310,281 | $28,660,655 | |
| ARGX | Argenx SE | +13,606 | 76,336 | $55,744,364 | |
| INSM | INSMED Inc | +13,371 | 224,271 | $36,672,793 | |
| KYMR | Kymera Therapeutics, Inc. | +9,516 | 145,816 | $12,145,014 | |
| BBIO | BridgeBio Pharma, Inc. | +7,731 | 267,031 | $19,829,722 | |
| RVMD | Revolution Medicines, Inc. | +3,564 | 119,464 | $11,617,874 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 86,650 | $19,819,454 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 884,121 | $18,522,334 | |
| BSX | Boston Scientific Corp | 293,152 | $18,395,288 | |
| TEM | Tempus AI, Inc. | 256,269 | $11,588,484 | |
| ATAI | AtaiBeckley Inc. | 1,709,359 | $6,051,130 | |
| PCSC | Perceptive Capital Solutions Corp | 37,686 | $413,415 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 162,800 | $23,089,924 | |
| EXAS | EXACT SCIENCES CORP | 147,750 | $15,005,490 | |
| LEGN | Legend Biotech Corp | 408,652 | $8,884,094 | |
| SLNO | Soleno Therapeutics Inc | 135,100 | $6,255,130 | |
| QURE | uniQure N.V. | 205,247 | $4,911,560 | |
| PRAX | Praxis Precision Medicines, Inc. | 14,951 | $4,406,657 | |
| MLTX | MoonLake Immunotherapeutics | 187,600 | $2,472,568 | |
| IRON | Disc Medicine, Inc. | 27,100 | $2,152,011 | |
| VIR | Vir Biotechnology, Inc. | 240,500 | $1,450,215 | |
| No positions match the current search. | ||||
26 positions ·
$478,546,642 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ARGX |
Argenx SE
Healthcare
|
Added | 76,336 | $55,744,364 | 11.65% | |
| ICLR |
Icon PLC
Healthcare
|
Added | 358,500 | $39,671,610 | 8.29% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 224,271 | $36,672,793 | 7.66% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 310,281 | $28,660,655 | 5.99% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 505,809 | $28,573,150 | 5.97% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 121,877 | $24,374,181 | 5.09% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 494,019 | $24,285,974 | 5.07% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Reduced | 187,413 | $23,100,526 | 4.83% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 412,497 | $21,746,841 | 4.54% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 267,031 | $19,829,722 | 4.14% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 86,650 | $19,819,454 | 4.14% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 179,322 | $18,900,538 | 3.95% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
NEW | 884,121 | $18,522,334 | 3.87% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 293,152 | $18,395,288 | 3.84% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Added | 573,815 | $14,351,113 | 3.00% | |
| FTRE |
Fortrea Holdings Inc.
Healthcare
|
Added | 1,307,560 | $12,317,215 | 2.57% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Added | 145,816 | $12,145,014 | 2.54% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 119,464 | $11,617,874 | 2.43% | |
| TEM |
Tempus AI, Inc.
Healthcare
|
NEW | 256,269 | $11,588,484 | 2.42% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 2,060,427 | $11,394,161 | 2.38% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 214,291 | $8,511,638 | 1.78% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 238,673 | $8,439,477 | 1.76% | |
| ATAI |
AtaiBeckley Inc.
Healthcare
|
NEW | 1,709,359 | $6,051,130 | 1.26% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Held | 4,390 | $2,023,746 | 0.42% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 46,300 | $1,395,945 | 0.29% | |
| PCSC |
Perceptive Capital Solutions Corp
Financial Services
|
NEW | 37,686 | $413,415 | 0.09% |